Published in Coron Artery Dis on May 01, 2003
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol (2006) 3.91
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
Self-organized patchiness in asthma as a prelude to catastrophic shifts. Nature (2005) 3.82
Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry (2004) 3.64
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol (2009) 3.39
Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science (2013) 3.26
Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell (2012) 3.21
PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry (2006) 2.78
Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol (2005) 2.65
Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. J Am Coll Cardiol (2009) 2.64
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab (2007) 2.51
Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. Int J Radiat Oncol Biol Phys (2007) 2.33
Exercise-induced ST-segment elevation in ECG lead aVR is a useful indicator of significant left main or ostial LAD coronary artery stenosis. JACC Cardiovasc Imaging (2011) 2.21
Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther (2006) 2.04
4-[18F]-tetraphenylphosphonium as a PET tracer for myocardial mitochondrial membrane potential. JACC Cardiovasc Imaging (2012) 1.94
Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann Neurol (2006) 1.87
The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.87
Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med (2006) 1.87
Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. Radiother Oncol (2008) 1.86
Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imaging (2009) 1.84
Topographical distribution of pulmonary perfusion and ventilation, assessed by PET in supine and prone humans. J Appl Physiol (1985) (2002) 1.83
Neutrophil metabolic activity but not neutrophil sequestration reflects the development of pancreatitis-associated lung injury. Crit Care Med (2002) 1.67
Implicit transfer of motor strategies in mental rotation. Brain Cogn (2003) 1.65
Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol (2007) 1.59
Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg (2008) 1.56
Hippocampal function in posttraumatic stress disorder. Hippocampus (2004) 1.54
A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. Neuroimage (2003) 1.49
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia. Ann Neurol (2014) 1.47
FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer (2002) 1.46
Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks. Arch Gen Psychiatry (2004) 1.44
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol (2013) 1.44
Quantification of regional ventilation-perfusion ratios with PET. J Nucl Med (2003) 1.42
Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation. Life Sci (2005) 1.39
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg (2003) 1.39
Who should read and interpret 18F-FDG PET studies? J Nucl Med (2003) 1.38
PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants. Med Phys (2007) 1.32
A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J Neurosurg (2006) 1.32
Coregistration of head CT comparison studies: assessment of clinical utility. Acad Radiol (2003) 1.31
MRI-based nonrigid motion correction in simultaneous PET/MRI. J Nucl Med (2012) 1.31
Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia. Biol Psychiatry (2003) 1.29
CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder. PLoS One (2012) 1.29
Resting metabolic activity in the cingulate cortex and vulnerability to posttraumatic stress disorder. Arch Gen Psychiatry (2009) 1.29
Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions. AJR Am J Roentgenol (2008) 1.28
Striatal dopamine release in sequential learning. Neuroimage (2007) 1.25
Mutations in the gene DNAJC5 cause autosomal dominant Kufs disease in a proportion of cases: study of the Parry family and 8 other families. PLoS One (2012) 1.25
Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry (2007) 1.25
Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. AJR Am J Roentgenol (2005) 1.24
Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest (2004) 1.23
Flare response in 18F-fluoride ion PET bone scanning. AJR Am J Roentgenol (2006) 1.21
Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat (2007) 1.21
MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling. Circ Res (2013) 1.19
Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry. Genet Med (2010) 1.17
Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience. Radiology (2006) 1.17
Accelerated triacylglycerol turnover kinetics in hearts of diabetic rats include evidence for compartmented lipid storage. Am J Physiol Endocrinol Metab (2005) 1.16
Coupling of mitochondrial fatty acid uptake to oxidative flux in the intact heart. Biophys J (2002) 1.15
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol (2005) 1.14
In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry (2005) 1.14
Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates. Proc Natl Acad Sci U S A (2007) 1.14
Bowel hot spots at PET-CT. Radiographics (2007) 1.14
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2002) 1.10
Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J (2013) 1.09
Cerebellar vermis involvement in cocaine-related behaviors. Neuropsychopharmacology (2006) 1.08
Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus. Mol Imaging Biol (2008) 1.08
A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia. Behav Brain Res (2008) 1.07
Explicit motor memory activates the striatal dopamine system. Neuroreport (2008) 1.05
Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. Int J Mol Med (2004) 1.04
Striatal dopamine release during unrewarded motor task in human volunteers. Neuroreport (2003) 1.03
Dopamine release during human emotional processing. Neuroimage (2009) 1.03
FDG-PET CT for tumor imaging. J Am Coll Radiol (2007) 1.03
Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI. Proc Natl Acad Sci U S A (2013) 1.02
False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol (2004) 1.01
Effects of burn injury, cold stress and cutaneous wound injury on the morphology and energy metabolism of murine brown adipose tissue (BAT) in vivo. Life Sci (2011) 1.01
Iodine-124 as a label for pharmacological PET imaging. Mol Pharm (2011) 1.00
Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology (2002) 0.99
The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). Behav Brain Res (2002) 0.97
Direct comparison of rest and adenosine stress myocardial perfusion CT with rest and stress SPECT. J Nucl Cardiol (2010) 0.97
Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging. J Nucl Med (2005) 0.96
A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder. Neuropsychopharmacology (2008) 0.94
Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT. Radiographics (2006) 0.94
Homocysteine impairs coronary microvascular dilator function in humans. J Am Coll Cardiol (2002) 0.93
Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am J Hum Genet (2002) 0.93